These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 38078905)

  • 1. Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function, and prevents sudden arrhythmic death in failing hearts.
    Joshi P; Estes S; DeMazumder D; Knollmann BC; Dey S
    Elife; 2023 Dec; 12():. PubMed ID: 38078905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function and prevents sudden arrhythmic death in failing hearts.
    Joshi P; Estes S; DeMazumder D; Knollmann BC; Dey S
    bioRxiv; 2023 Aug; ():. PubMed ID: 37662391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RyR2 inhibition with dantrolene is antiarrhythmic, prevents further pathological remodeling, and improves cardiac function in chronic ischemic heart disease.
    Schmeckpeper J; Kim K; George SA; Blackwell DJ; Brennan JA; Efimov IR; Knollmann BC
    J Mol Cell Cardiol; 2023 Aug; 181():67-78. PubMed ID: 37285929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenytoin Reduces Activity of Cardiac Ryanodine Receptor 2; A Potential Mechanism for Its Cardioprotective Action.
    Ashna A; van Helden DF; Dos Remedios C; Molenaar P; Laver DR
    Mol Pharmacol; 2020 Apr; 97(4):250-258. PubMed ID: 32015008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial ROS Drive Sudden Cardiac Death and Chronic Proteome Remodeling in Heart Failure.
    Dey S; DeMazumder D; Sidor A; Foster DB; O'Rourke B
    Circ Res; 2018 Jul; 123(3):356-371. PubMed ID: 29898892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dantrolene, a therapeutic agent for malignant hyperthermia, markedly improves the function of failing cardiomyocytes by stabilizing interdomain interactions within the ryanodine receptor.
    Kobayashi S; Yano M; Suetomi T; Ono M; Tateishi H; Mochizuki M; Xu X; Uchinoumi H; Okuda S; Yamamoto T; Koseki N; Kyushiki H; Ikemoto N; Matsuzaki M
    J Am Coll Cardiol; 2009 May; 53(21):1993-2005. PubMed ID: 19460614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dantrolene prevents ventricular tachycardia by stabilizing the ryanodine receptor in pressure- overload induced failing hearts.
    Kajii T; Kobayashi S; Shiba S; Fujii S; Tamitani M; Kohno M; Nakamura Y; Nanno T; Kato T; Okuda S; Uchinoumi H; Oda T; Yamamoto T; Yano M
    Biochem Biophys Res Commun; 2020 Jan; 521(1):57-63. PubMed ID: 31635807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox modification of ryanodine receptors underlies calcium alternans in a canine model of sudden cardiac death.
    Belevych AE; Terentyev D; Viatchenko-Karpinski S; Terentyeva R; Sridhar A; Nishijima Y; Wilson LD; Cardounel AJ; Laurita KR; Carnes CA; Billman GE; Gyorke S
    Cardiovasc Res; 2009 Dec; 84(3):387-95. PubMed ID: 19617226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression.
    Mohamed BA; Hartmann N; Tirilomis P; Sekeres K; Li W; Neef S; Richter C; Zeisberg EM; Kattner L; Didié M; Guan K; Schmitto JD; Lehnart SE; Luther S; Voigt N; Seidler T; Sossalla S; Hasenfuss G; Toischer K
    Sci Transl Med; 2018 Sep; 10(458):. PubMed ID: 30209242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(14):1-74. PubMed ID: 23074465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic effects of dantrolene in human diseased cardiomyocytes.
    Hartmann N; Pabel S; Herting J; Schatter F; Renner A; Gummert J; Schotola H; Danner BC; Maier LS; Frey N; Hasenfuss G; Fischer TH; Sossalla S
    Heart Rhythm; 2017 Mar; 14(3):412-419. PubMed ID: 27650424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
    Fujii S; Kobayashi S; Chang Y; Nawata J; Yoshitomi R; Tanaka S; Kohno M; Nakamura Y; Ishiguchi H; Suetomi T; Uchinoumi H; Oda T; Okuda S; Okamura T; Yamamoto T; Yano M
    J Mol Cell Cardiol; 2023 May; 178():36-50. PubMed ID: 36963751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ryanodine receptor inhibition with acute dantrolene treatment reduces arrhythmia susceptibility in human hearts.
    George SA; Brennan-McLean JA; Trampel KA; Rytkin E; Faye NR; Knollmann BC; Efimov IR
    Am J Physiol Heart Circ Physiol; 2023 Oct; 325(4):H720-H728. PubMed ID: 37566110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ryanodine receptor phosphorylation by calcium/calmodulin-dependent protein kinase II promotes life-threatening ventricular arrhythmias in mice with heart failure.
    van Oort RJ; McCauley MD; Dixit SS; Pereira L; Yang Y; Respress JL; Wang Q; De Almeida AC; Skapura DG; Anderson ME; Bers DM; Wehrens XH
    Circulation; 2010 Dec; 122(25):2669-79. PubMed ID: 21098440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dantrolene prevents arrhythmogenic Ca2+ release in heart failure.
    Maxwell JT; Domeier TL; Blatter LA
    Am J Physiol Heart Circ Physiol; 2012 Feb; 302(4):H953-63. PubMed ID: 22180651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of ryanodine receptor after ischemia-reperfusion increases propensity of Ca
    Bovo E; Mazurek SR; Zima AV
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H1032-H1040. PubMed ID: 30028204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.
    Zhao YT; Valdivia CR; Gurrola GB; Powers PP; Willis BC; Moss RL; Jalife J; Valdivia HH
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):E1669-77. PubMed ID: 25775566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dantrolene rescues aberrant N-terminus intersubunit interactions in mutant pro-arrhythmic cardiac ryanodine receptors.
    Seidel M; Thomas NL; Williams AJ; Lai FA; Zissimopoulos S
    Cardiovasc Res; 2015 Jan; 105(1):118-28. PubMed ID: 25411383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox modification of ryanodine receptors contributes to sarcoplasmic reticulum Ca2+ leak in chronic heart failure.
    Terentyev D; Györke I; Belevych AE; Terentyeva R; Sridhar A; Nishijima Y; de Blanco EC; Khanna S; Sen CK; Cardounel AJ; Carnes CA; Györke S
    Circ Res; 2008 Dec; 103(12):1466-72. PubMed ID: 19008475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of calmodulin regulation of RyR2 in controlling heart rhythm, the progression of heart failure and the antiarrhythmic action of dantrolene.
    Walweel K; Oo YW; Laver DR
    Clin Exp Pharmacol Physiol; 2017 Jan; 44(1):135-142. PubMed ID: 27626620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.